Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Total Liabilities: 2012-2024

Historic Total Liabilities for CorMedix (CRMD) over the last 12 years, with Dec 2024 value amounting to $34.2 million.

  • CorMedix's Total Liabilities rose 1896.05% to $376.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $376.7 million, marking a year-over-year increase of 1896.05%. This contributed to the annual value of $34.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that CorMedix reported Total Liabilities of $34.2 million as of FY2024, which was up 389.91% from $7.0 million recorded in FY2022.
  • In the past 5 years, CorMedix's Total Liabilities ranged from a high of $34.2 million in FY2024 and a low of $5.1 million during FY2020.
  • For the 2-year period, CorMedix's Total Liabilities averaged around $20.6 million, with its median value being $20.6 million (2022).
  • As far as peak fluctuations go, CorMedix's Total Liabilities fell by 12.77% in 2020, and later increased by 20.89% in 2021.
  • CorMedix's Total Liabilities (Yearly) stood at $5.1 million in 2020, then increased by 20.89% to $6.1 million in 2021, then climbed by 13.52% to $7.0 million in 2022, then reached $34.2 million in 2024.